856106-63-3

Basic information

• Product Name: 2,4-dihydroxy-5-iodobenzoic acid
• Synonyms: 2,4-dihydroxy-5-iodobenzoic acid
• CAS NO: 856106-63-3
• Molecular Weight: 280.019
• Mol File: 856106-63-3.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: 2,4-dihydroxy-5-iodobenzoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 2,4-dihydroxy-5-iodobenzoic acid(856106-63-3)
• EPA Substance Registry System: 2,4-dihydroxy-5-iodobenzoic acid(856106-63-3)

Safety Data

• Hazardous Substances Data: 856106-63-3(Hazardous Substances Data)

Usage

General Description

2,4-dihydroxy-5-iodobenzoic acid, also known as 5-Iodo-2,4-dihydroxybenzoic acid, is a chemical compound with the molecular formula C7H5IO4. It is a derivative of benzoic acid, which is commonly found in natural sources such as fruits and plants. The compound is known for its potential antibacterial and antioxidant properties, making it a valuable component in pharmaceutical and cosmetic industries. Its structure contains two hydroxyl groups and an iodine atom, providing it with unique properties and biological activities. It has been studied for its potential application in treating bacterial infections and as a natural preservative in food and cosmetic products.

Upstream product

• 60-29-7 diethyl ether 
• 89-86-1 4-hydroxysalicylic acid 
• 7790-99-0 Iodine monochloride 

Downstream Products

• 913622-34-1 1-(2-methoxy-3,6-bis(methoxymethoxy)-5-nitrophenyl)propan-2-yl 5-iodo-2,4-dihydroxybenzoate 
• 1404435-76-2 2-(4-(carboxymethoxy)phenyl)-3-((3-chlorophenyl)ethynyl)-6-hydroxybenzofuran-5-carboxylic acid 
• 1441379-99-2 methyl 2-(4-(6-((3-chlorophenyl)ethynyl)-2,2-dimethyl-4-oxo-4H-[1,3]dioxino[5,4-f ]benzofuran-7-yl)phenoxy)acetate 
• 1441379-88-9 methyl 2-(4-(6-iodo-2,2-dimethyl-4-oxo-4H-[1,3]dioxino[5,4-f ]-benzofuran-7-yl)phenoxy)acetate 
• 1441379-76-5 methyl 2-(4-((7-methoxy-2,2-dimethyl-4-oxo-4H-benzo[d][1,3]dioxin-6-yl)ethynyl)-phenoxy)acetate 
• 1404435-75-1 2-(3-(carboxymethoxy)phenyl)-3-((3-chlorophenyl)ethynyl)-6-hydroxybenzofuran-5-carboxylic acid 
• 1441379-94-7 methyl 2-(3-(6-((3-chlorophenyl)ethynyl)-2,2-dimethyl-4-oxo-4H-[1,3]dioxino[5,4-f ]benzofuran-7-yl)phenoxy)acetate 
• 1441379-82-3 methyl 2-(3-(6-iodo-2,2-dimethyl-4-oxo-4H-[1,3]dioxino[5,4-f ]-benzofuran-7-yl)phenoxy)acetate 
• 1441379-70-9 methyl 2-(3-((7-methoxy-2,2-dimethyl-4-oxo-4H-benzo[d][1,3]dioxin-6-yl)ethynyl)phenoxy)acetate 
• 1404435-65-9 3-((3-(carboxymethoxy)phenyl)ethynyl)-6-hydroxy-2-(4-(trifluoromethoxy)phenyl)benzofuran-5-carboxylic acid 
• 1404435-64-8 6-hydroxy-3-(thiophen-3-ylethynyl)-2-(4-(trifluoromethoxy)-phenyl)benzofuran-5-carboxylic acid 
• 1404435-63-7 3-((3,4-dichlorophenyl)ethynyl)-6-hydroxy-2-(4-(trifluoromethoxy)phenyl)benzofuran-5-carboxylic acid 
• 1404435-62-6 3-((3-chlorophenyl)ethynyl)-6-hydroxy-2-(4-(trifluoromethoxy)-phenyl)benzofuran-5-carboxylic acid 
• 1441379-19-6 methyl 2-(3-((2,2-fimethyl-4-oxo-7-(4-(trifluoromethoxy)phenyl)-4H-[1,3]dioxino[5,4-f ]benzofuran-6-yl)ethynyl)phenoxy)acetate 

Relevant articles and documents

A potent and selective small-molecule inhibitor for the lymphoid-specific tyrosine phosphatase (LYP), a target associated with autoimmune diseases

Lymphoid-specific tyrosine phosphatase (LYP), a member of the protein tyrosine phosphatase (PTP) family of signaling enzymes, is associated with a broad spectrum of autoimmune diseases. Herein we describe our structure-based lead optimization efforts with

TYROSINE PHOSPHATASE INHIBITORS AND USES THEREOF TO MODULATE THE ACTIVITY OF LYP

A variety of benzofurans and indole derivatives some with an acetyl linker are disclosed herein. These compounds are not highly charged at physiological pH and have good bioavailability characteristics. These compounds exhibit selective or at least preferential affinity for the active sites of various sub-sets of protein tyrosine phosphatases. The lymphoid- specific tyrosine phosphatase (Lyp) has received enormous attention because of the finding that a single- nucleotide polymorphism (SNP) in the gene (PTPN22) encoding Lyp is associated with several autoimmune diseases, including type I diabetes. Many of these compounds and pharmaceutically acceptable salts thereof are novel therapeutic compounds useful for the treatment of various diseases including a number of autoimmune diseases.

Iodination of Resorcinol, 5-Methoxyresorcinol, Phloroglucinol and Resorcyclic Acid

-